Systematic Review
Accepted on 20 Nov 2025
Visualized Knowledge Mapping on the Current Research Trends and Emerging Areas of Neuroimmune Modulation in the Past Two Decades
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Type at least 3 characters
1,457 articles
Mini Review
Published on 20 Nov 2025
Neuroimmune modulatory effects of the NLRP3 inflammasome: the role of sex and living environment in brain affecting conditions
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1711656
- 508 views
Review
Published on 20 Nov 2025
The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1656422
- 238 views
Review
Published on 20 Nov 2025
Decoding tRNA dynamics in neuroimmune disorders: mechanistic insights, diagnostic innovations, and therapeutic opportunities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1642370
- 287 views
Correction
Published on 20 Nov 2025
Correction: Polysialic acid restrains inflammatory monocyte maturation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1731973
- 320 views
Review
Published on 19 Nov 2025
Vaccination and COVID-19: impact on long-COVID
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1686572
- 620 views
Original Research
Published on 19 Nov 2025
Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568157
- 719 views
Original Research
Accepted on 18 Nov 2025
Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 18 Nov 2025
Dual Role of Complement in Neuronal Repair
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Opinion
Accepted on 17 Nov 2025
Beyond the cut-off: harmonizing kappa free light chain index using likelihood ratios improves the clinical interpretation in the diagnosis of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Published on 11 Nov 2025
Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1661791
- 581 views
Original Research
Published on 07 Nov 2025
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658182
- 945 views
Original Research
Published on 04 Nov 2025
Sex differences in abnormal gluten response and predictors of gluten sensitivity in patients with schizophrenia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1696763
- 551 views
Review
Published on 30 Oct 2025
The mechanisms of specialized pro-resolving mediators in pain relief: neuro-immune and neuroglial regulations
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1634724
- 1,007 views
Original Research
Published on 29 Oct 2025
Antibodies to myelin oligodendrocyte glycoprotein in optic perineuritis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1657600
- 786 views
Original Research
Published on 28 Oct 2025
Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1682183
- 1,530 views